The Impact of Switching to a Second Antifibrotic in Patients With Idiopathic Pulmonary Fibrosis: A Retrospective Multicentre Study From the EMPIRE Registry-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Impact of Switching to a Second Antifibrotic in Patients With Idiopathic Pulmonary Fibrosis: A Retrospective Multicentre Study From the EMPIRE Registry

Published:2024-02 Issue:2 Volume:60 Page:80-87
ISSN:0300-2896
Container-title:Archivos de Bronconeumología
language:en
Short-container-title:Archivos de Bronconeumología

Author:

Gregor Jakub,Adir Yochai,Šterclová Martina,Mogulkoc Nesrin,Kramer Mordechai R.,Doubková Martina,Plačková Martina,Müller Veronika,Studnicka Michael,Žurková Monika,Lacina Ladislav,Lewandowska Katarzyna,Bartoš Vladimír,Ovesná Petra,Májek Ondřej,Koziar Vašáková Martina

Funder

F. Hoffmann-La Roche

Boehringer Ingelheim

Roche

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference26 articles.

1. Long-term course and prognosis of idiopathic pulmonary fibrosis in the new millennium;Nathan;Chest,2011

2. Mortality and survival in idiopathic pulmonary fibrosis: a systematic review and meta-analysis;Zheng;ERJ Open Res,2022

3. Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis;Wollin;Eur Respir J,2015

4. Pirfenidone: a review of its use in idiopathic pulmonary fibrosis;Kim;Drugs,2015

5. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis;King;N Engl J Med,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP